Alerts will be sent to your verified email
Verify Email
PFIZER
|
Pfizer
|
Eris Lifesciences
|
Wockhardt
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
4.7 % | 9.3 % | 10.6 % |
|
Financials
|
|||
|
5 yr Average ROE
|
18.39 % | 19.85 % | -3.81 % |
|
5yr average Equity Multiplier
|
1.28 | 1.5 | 2.26 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.58 | 0.39 |
|
5yr Avg Net Profit Margin
|
24.04 % | 25.85 % | -4.46 % |
|
Price to Book
|
5.18 | 7.2 | 5.9 |
|
P/E
|
31.55 | 60.59 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-2.02 Days | -99.43 Days | -118.47 Days |
|
Inventory Days
|
49.44 Days | 26.22 Days | 68.12 Days |
|
Days Receivable
|
26.74 Days | 61.69 Days | 71.63 Days |
|
Days Payable
|
81.1 Days | 164.23 Days | 260.3 Days |
|
5yr Average Interest Coverage Ratio
|
170.95 | 94.87 | -0.67 |
|
5yr Avg ROCE
|
23.56 % | 21.14 % | -1.45 % |
|
5yr Avg Operating Profit Margin
|
30.56 % | 34.25 % | 3.11 % |
|
5 yr average Debt to Equity
|
0.0 | 0.29 | 0.71 |
|
5yr CAGR Net Profit
|
65.36 % | 5.74 % | 46.24 % |
|
5yr Average Return on Assets
|
14.39 % | 15.49 % | -1.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.92 % | 54.85 % | 49.09 % |
|
Share Pledged by Promoters
|
0.0 | 18.51 % | 18.24 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 2.19 % | -18.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.65 % | 6.48 % | 7.53 % |
|
Pfizer
|
Eris Lifesciences
|
Wockhardt
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|